4IG
GILD icon

440 Investment Group’s Gilead Sciences GILD Stock Holding History

440 Investment Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$1.56M Sell
21,849
-12,534
-36% -$952K 1.11% 24
2017
Q3 		$2.79M Buy
34,383
+8,688
+34% +$664K 2.12% 12
2017
Q2 		$1.82M Buy
25,695
+600
+2% +$39.9K 1.45% 20
2017
Q1 		$1.7M Buy
+25,095
New +$1.76M 1.52% 15

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

440 Investment Group's GILD Position: Q4 2017 in Review

440 Investment Group reduced its Gilead Sciences (GILD) stake by 36% in Q4 2017, selling an estimated $952K and leaving 21,849 shares worth $1.56M. The position accounts for 1.11% of the portfolio, ranked #24.

440 Investment Group first reported a position in GILD in Q1 2017 and has held it in 4 quarters since. The position peaked at $2.79M in Q3 2017. 1,576 funds tracked by Wall St. Rank hold GILD as of Q4 2017.

  • 440 Investment Group held 21,849 shares of Gilead Sciences worth $1.56M as of Q4 2017.
  • 440 Investment Group sold 12,534 Gilead Sciences shares in Q4 2017, an estimated $952K.
  • Gilead Sciences made up 1.11% of 440 Investment Group's portfolio in Q4 2017, its #24 holding.
  • 440 Investment Group first reported a position in Gilead Sciences in Q1 2017 and has held it in 4 quarters since.
  • 440 Investment Group's Gilead Sciences position peaked at $2.79M in Q3 2017.
  • 1,576 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2017.

Based on 440 Investment Group's 13F filing for Q4 2017, filed 16 Jan 2018.